No Benefit Seen With Everolimus in Early Breast Cancer ...Middle East

Medscape - News
Adding everolimus to adjuvant hormone therapy for early ER+, HER2- breast cancer does not offer any benefit over hormone therapy alone, according to results of the phase 3 UNIRAD study. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( No Benefit Seen With Everolimus in Early Breast Cancer )

Apple Storegoogle play

Also on site :

Most viewed in News